Breast Cancer Trial, Recruiting NCT07080476 Sponsor: Universiteit Antwerpen Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07080476
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women who have previously been treated for breast cancer
  • People who have had persistent swelling (lasting more than 6 months) in the breast and/or the trunk area (such as the chest, back, or side), with that swelling confirmed at least six months after finishing radiotherapy
  • People whose swelling has been measured and confirmed using a specific scoring tool called the BrEQ (a score of 9 or higher is required)
  • People whose tissue fluid levels, measured using a device called a LymphScanner, show swelling above a certain threshold in the trunk or breast area (confirm with trial site for exact values)
  • People who show at least one visible physical sign of breast or trunk swelling, such as noticeable puffiness compared to the other side of the body, a visible bra imprint on the skin, or a dimpled "orange peel" texture on the breast

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a skin infection or open wound in the breast or trunk area at the time of joining, which would make it impossible to apply kinesio tape
  • People under 18 years of age
  • People who are not able to read and understand Dutch
  • People who have had a mastectomy (full surgical removal of the breast)
  • People whose breast cancer has spread to other parts of the body (metastatic breast cancer)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32 472 74 16 77

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universiteit Antwerpen
Registry
ClinicalTrials.gov
Start date
25 August 2025
Est. completion
30 April 2028

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Change in Breast Edema Questionnaire (BrEQ) score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov